Expanding footprint Lupin Diagnostics is rapidly expanding with 600+ collection centers and 36+ laboratories across East, West, Central and South India, plus plans to open hundreds more collection centers in South India and Tamil Nadu by FY2025, signaling strong growth opportunities for regional partnerships and enterprise lab services.

Scaleable home collection With 500+ phlebotomists offering free home collection and a temperature controlled logistics network managed by 200+ executives, there is a clear value proposition for outsourced sample collection, patient access programs, and partnerships with clinics seeking convenient patient experiences.

Quality and compliance NABL accredited labs (30%) aligned with CAP guidelines, stringent quality control, and personalized patient friendly reports position Lupin Diagnostics as a trusted partner for hospitals and clinics prioritizing reliability, accreditation support, and standardized result delivery.

Tech enabled Adoption of modern tech stack including React, Next.js, PWAs, and tracking capabilities suggests opportunities to offer digital lab services, portal integrations, real-time status updates for orders, and data integrations with hospital EHR systems.

Commercial growth potential Revenue in the multi-million range with a growing network and expansion plans indicates potential upsell to enterprise clients, collaborations with large hospital networks, diagnostic partnerships, and cross-sell of specialized tests leveraging existing lab capacities.